Literature DB >> 14656977

COX-3--a virtual pain target in humans?

Jan M Schwab1, Thomas Beiter, Juergen U Linder, Stefan Laufer, Joachim E Schulz, Richard Meyermann, Hermann J Schluesener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14656977     DOI： 10.1096/fj.03-0595lte

Source DB:  PubMed          Journal:  FASEB J        ISSN： 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  6 in total

Review 1.  [Pain therapy with antipyretic analgesics].

Authors:  B Hinz; K Brune
Journal:  Orthopade       Date:  2007-01       Impact factor: 1.087

Review 2.  The role of cyclooxygenase in gastric mucosal protection.

Authors:  Katya Gudis; Choitsu Sakamoto
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 3.  Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action.

Authors:  Samir S Ayoub
Journal:  Temperature (Austin)       Date:  2021-03-16

Review 4.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

Review 5.  Effects of prostaglandins and COX-inhibiting drugs on skeletal muscle adaptations to exercise.

Authors:  Todd A Trappe; Sophia Z Liu
Journal:  J Appl Physiol (1985)       Date:  2013-03-28

6.  Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model.

Authors:  Takeshi Inoue; Satoshi Anai; Sayuri Onishi; Makito Miyake; Nobumichi Tanaka; Akihide Hirayama; Kiyohide Fujimoto; Yoshihiko Hirao
Journal:  BMC Urol       Date:  2013-01-05       Impact factor: 2.264
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.